Processa Pharmaceuticals (PCSA) Q1 2025 Earnings

20MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.18
-1.04
-0.91
-0.77

Details

Expected EPS
-0.845
Actual EPS
-0.77
Surprise EPS
0.07
Surprise Percent
+8.88%

Description

Processa Pharmaceuticals (PCSA) has reported earnings of -0.77 per share for Q1 2025.

0 Comments

Share your thoughts